References
- Pickard J, Jochen AL, Sadur CN, Hofeldt FD. Cushing's syndrome in pregnancy. Obstet Gynecol Surv 1990; 45: 87–93
- Bugalho MJ, Leite V, Sobrinho LG, et al. Stimulation of a Cortisol producing adrenal adenoma by chorionic gonadotrophin. Arqui Med 1992; 6: 250–2
- Pabon JE, Li X, Lei ZM, et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1996; 81: 2397–400
- Lyons J, Landis CA, Harsh G, et al. Two G protein oncogenes in endocrine tumors. Science 1990; 249: 655–9
- Williamson EA, Johnson SJ, Foster S, et al. G protein gene mutations in patients with multiple endocrinopathies. J Clin Endocrinol Metab 1995; 80: 1702–5
- Dötsch J, Kiess W, Hänze J, et al. Gsα Mutation at codon 201 in pituitary adenoma causing gigantism in a 6-year-old boy with McCune-Albright syndrome. J Clin Endocrinol Metab 1996; 81: 3839–42
- Lei ZM, Rao ChV, Kornyei JL, et al. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993; 132: 2262–70
- Givens JR, Anderson RN, Wiser WL, et al. A gonadotropin-responsive adrenocortical adenoma. J Clin Endocrinol Metab 1974; 38: 126–33
- Seron-Ferre M, Lawrence CC, Jaffe RB. Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 1978; 46: 834–7
- Lauritzen C, Lehmann WD. Levels of chorionic gonadotrophin in the newborn infant and their relationship to adrenal dehydroepiandrosterone. J Endocrinol 1967; 39: 173–82
- Zhou XL, Lei ZM, Rao ChV. Human adrenal cortical H295R cells contain functional luteinizing hormone/chorionic gonadotropin receptors: a potential explanation for increased androgen levels in chorionic anovulatory women. Annual Meeting of the Society for Gynecologic Investigation. J Soc Gynecol Invest 1998; 5(1)50A
- Landis CA, Masters SB, Spada A, et al. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989; 340: 692–6
- O'Sullivan CO, Bartom CM, Staddon SL, et al. Activating mutations of gsp oncogene in human thyroid adenomas. Mol Carcinogen 1991; 4: 345–9
- Suarez HG, Villard JA, Caillou B, et al. gsp Mutations in thyroid tumours. Oncogene 1991; 6: 677–9
- Tordjman K, Stern N, Ouaknine G, et al. Activating mutations of the Gsα-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 1993; 77: 765–9
- Williamson EA, Daniels M, Foster S, et al. Gsα and Gi2α mutations in clinically nonfunctioning pituitary tumours. Clin Endocrinol 1994; 41: 815–20
- Williamson EA, Ince PG, Harrison D, et al. G protein mutations in human pituitary adreno-corticotrophic hormone-secreting adenomas. Eur J Clin Invest 1995; 25: 128–31
- Weinstein LS, Shenker A, Gejman PV. Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med 1991; 325: 1688–95
- Liu L, Jaffe R, Borowski GD, Rose LI. Exacerbation of Cushing's disease during pregnancy. Am J Obstet Gynecol 1983; 145: 110–11
- Reschini E, Giustina G, Crosignani PG, D'Alberton A. Spontaneous remission of Cushing syndrome after termination of pregnancy. Obstet Gynecol 1978; 51: 598–602